Archive

Home 9 Publication archive Dermapharm

DERMAPHARM HOLDING SE

Corporate News

April 13, 2021 | Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures

Corporate news to the archive Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures Revenue and earnings up due to organic growth and successful acquisitions Vaccine production to commence in May 2021 ...

February 12, 2021 | Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021

Corporate news to the archive Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021 Grünwald, February 12, 2021 - Dermapharm Holding ...

November 16, 2020 | Dermapharm Holding SE continues on its growth course in third quarter of 2020

Corporate news to the archive Dermapharm Holding SE continues on its growth course in third quarter of 2020 Group revenue rose by 11.5% to EUR 577.2 million Adjusted Group EBITDA increased by 4.4% to EUR 139.0 million; corresponding ...

Ad hoc News

Select Year

12 February 2021 | Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021

Ad hoc news to the archive Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021 Grünwald, February 12, 2021 - Dermapharm Holding SE (WKN: ...

| Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE

Ad hoc news to the archive Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE Grünwald, September 10, 2020 – Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) and BioNTech SE, Mainz, Germany, ...

| Dermapharm Holding SE sets offer price at EUR 28.00 per share

Ad hoc news to the archive   Dermapharm Holding SE sets offer price at EUR 28.00 per share Grünwald, February 8, 2018 - Today, Dermapharm Holding SE (together with its consolidated subsidiaries, "Dermapharm", ISIN: ...